Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.
about
Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel diseaseAntibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importanceSpecific antibody response to oligomannosidic epitopes in Crohn's diseaseMicrobial biofilms and gastrointestinal diseasesCorrelation between Saccharomyces cerevisiae DNA in intestinal mucosal samples and anti-Saccharomyces cerevisiae antibodies in serum of patients with IBDGut mucosal response to food antigens in Crohn's disease.Environmental risk factors for inflammatory bowel disease.Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.Antibodies to Mycobacterium paratuberculosis and nine species of environmental mycobacteria in Crohn's disease and control subjectsMycobiota in gastrointestinal diseases.Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.Gut fungal microbiota: the Yin and Yang of inflammatory bowel disease.Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathyBiomarkers in inflammatory bowel disease: current practices and recent advances.Immunopathogenesis of IBD: current state of the art.The Fungal Mycobiome and Its Interaction with Gut Bacteria in the Host.Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitisFecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.Current understanding of fungal microflora in inflammatory bowel disease pathogenesisFungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.Circulating antibodies to Saccharomyces cerevisiae (bakers'/brewers' yeast) in gastrointestinal disease.Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease.Autoimmunity against type VII collagen in inflammatory bowel diseaseCandida albicans infection affords protection against reinfection via functional reprogramming of monocytes.The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.Serological antibodies in inflammatory bowel disease: a systematic review.An immunological link between Candida albicans colonization and Crohn's disease.Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives.Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot study.Predicting Outcomes and Tailoring Therapy in the Diagnosis and Treatment of IBD.Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.Fungi in Gastrointestinal Tracts of Human and Mice: from Community to Functions.Baker's yeast (Saccharomyces cerevisiae) antigen in obese and normal weight subjects.Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease.CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.The Mycobiome: A Neglected Component in the Microbiota-Gut-Brain Axis.IgG Antibodies Against Common Gut Bacteria Are More Diagnostic for Crohn's Disease Than IgG Against Mannan or Flagellin
P2860
Q24540418-DACFD91B-D693-45F0-BE18-07A671E77B91Q24540422-AE7D3CE5-8818-462B-B8F5-A108F9B726F8Q24669936-976EE0B9-6D0B-4B46-A97E-1356B94672AEQ26852574-EB85D41F-D105-4241-8CDA-49B46657BE8CQ28297789-0264CF90-D6C1-43F6-8DF0-EBE7A4C4C0BAQ30717067-ABA50FBC-07D5-47AC-90D3-B342F303142BQ33916393-C0C05CEB-BCDA-47F4-BA45-510343D50A9DQ34126171-CF0C613B-A211-44AA-8BDE-74C338830B84Q34376443-C0CA719E-FEEE-4CE2-B675-671890ED776DQ34447163-5AE10E5E-7C81-46FE-8E4C-A55C3210C85CQ34720198-29A8D12B-3CD8-4AC1-9D68-97AD34EBB5B9Q35358278-52C9593A-0CCA-4001-BBD3-E5AEFC7AAD12Q35361496-0D95310D-6937-4305-90FF-ABFEC6A8DA2EQ35534964-8EC8C148-E6F1-44DA-847B-131318E90F04Q35552641-1EA29A71-29EF-428E-A250-5F0025673D6AQ35840853-CC99E5BD-E502-4D30-B35D-A90B43788F04Q35857951-E61923AA-F811-4C01-BC14-F650C41E2498Q36271354-0640A910-3FC2-4BA9-B6F6-449D67FAB133Q36474498-D5526BF8-5044-4940-99D9-79B75F724C63Q37064590-C0FF55B7-1A86-43AF-AC8A-45F1E066CCA7Q37089171-173A0112-2B09-48E8-B999-06D35EDE6C59Q37118457-0105426E-BA32-4AA7-9F10-31B0D4D3B045Q37229595-F123E56A-619A-4437-B935-684F1A08F840Q37283648-08623CBB-8DB0-453D-B6F2-1ECC9024E882Q37295360-09379168-60B7-4267-8892-56A006776DE5Q37394444-C94A3C0F-2687-4704-BA74-1C0EB415D175Q37870433-583493BC-9139-44C1-82B7-91B8CE479697Q37954231-D641F77B-5ACB-4516-9539-1D7B49B3416FQ38121585-976366EE-BE85-4075-838F-A7438DC8BDE9Q38915531-FC424A7F-EBCE-4E5C-A4B4-749E4C83F46CQ40187132-1A9B9389-BF11-4A65-B3F4-D2344D9A5162Q40441902-8BE5D413-24C8-4007-8749-2330C396E5B2Q42233323-D4D9805F-FF89-419A-9223-8C71AA9F0F1BQ43886944-FACDF7CF-936E-47D4-956A-0709FB17F572Q46267304-237AF08D-5DA5-41F0-A7B7-C9D24412A534Q47410636-EB58B1C1-59F0-4935-BF04-ADE0ECE981EFQ47981584-BCC2B49C-B13F-44E6-90A5-B8AB4ABF8077Q49118975-70E7B19F-3AED-4193-AC09-1044CAA8E7FDQ52664476-07C03653-67C6-4782-9D31-5AD178504662Q57282776-4F29D3B0-F31C-4C0C-81DE-85EDCC264DF4
P2860
Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Antibody to selected strains o ...... a albicans in Crohn's disease.
@ast
Antibody to selected strains o ...... a albicans in Crohn's disease.
@en
Antibody to selected strains of Saccharomyces cerevisiae
@nl
type
label
Antibody to selected strains o ...... a albicans in Crohn's disease.
@ast
Antibody to selected strains o ...... a albicans in Crohn's disease.
@en
Antibody to selected strains of Saccharomyces cerevisiae
@nl
prefLabel
Antibody to selected strains o ...... a albicans in Crohn's disease.
@ast
Antibody to selected strains o ...... a albicans in Crohn's disease.
@en
Antibody to selected strains of Saccharomyces cerevisiae
@nl
P2093
P2860
P921
P356
P1433
P1476
Antibody to selected strains o ...... a albicans in Crohn's disease.
@en
P2093
P2860
P304
P356
10.1136/GUT.31.5.536
P407
P577
1990-05-01T00:00:00Z